HCA Healthcare, Inc. (HCA) Valuation
Historical valuation analysis based on 1279 data points (2021-09-14 to 2026-10-16)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated...
HCA Healthcare, Inc. (HCA) currently trades at a P/E ratio of 14.52 (historical range: 7.69–20.58, median: 13.99), placing it at the 59th percentile — near its historical average, P/S ratio of 1.27 (range: 0.83–1.82, 47th percentile — near its historical average), EV/EBITDA of 13.59 (range: 8.95–18.94, 46th percentile).
Over the historical period (2021-09-14 to 2026-10-16), HCA Healthcare, Inc.'s P/E ratio has expanded by 28% over the observed period (from an average of 12.5 to 15.9).
HCA Healthcare, Inc. trades near its historical valuation range, with most metrics close to their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 14.52 | 13.99 | 59th | near its historical average |
| P/S Ratio | 1.27 | 1.29 | 47th | near its historical average |
| EV/EBITDA | 13.59 | 13.81 | 46th | near its historical average |
| FCF Yield | 6.04% | 6.27% | 44th | near its historical average |
HCA Healthcare, Inc. (HCA) Valuation & P/E History
HCA Healthcare, Inc. (HCA) is a US-listed stock operating in the Healthcare sector, specifically the Services-General Medical & Surgical Hospitals, Nec industry currently trading at $458.84 with a market capitalization of $99.3 billion. This page provides historical valuation analysis for HCA based on 1279 data points covering 2021-09-14 to 2026-10-16. The P/E ratio of 14.52 is above the historical median of 13.99, placing HCA at the 59th percentile of its valuation range. The P/S ratio of 1.27 compares to a median of 1.29.
HCA Valuation Metrics & Historical Range
The valuation table above shows HCA Healthcare, Inc.'s current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether HCA is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests HCA is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for HCA Healthcare, Inc..
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is HCA Overvalued or Undervalued?
HCA Healthcare, Inc. trades near its historical valuation range, with most metrics close to their median levels. The overall valuation percentile of 51 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive HCA is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full HCA analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.HCA trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.